Dallas, Texas 05/28/2015 (Financialstrend) – Ceres Inc (NASDAQ:CERE) prospects in the Street are slowly sprouting. The stock has not had the best of runs in the recent years having been hit hard by concerns over genetically modified products. However, its prospects are finally looking good, having been awarded a patent for a genetic sequence derived from soybean.
Ceres Targeting More Licensing Revenue
The patent has the potential to have a big impact on the field of research especially in product development and plant transformation. The approved gene is especially of importance in biosynthetic processes that target commercial herbicides.
Ceres Inc (NASDAQ:CERE) plans to generate revenues from the patent by licensing the technology to other seed companies. The company has also announced that it is looking for other potential markets that the patented gene can be used. Signing of multiple licensing deals should be good for business as the company moves to generate more revenue even as genetically modified products continue to be marred with concerns in the U.S.
Ceres Biotechnology platform has already been found to be reliable for increasing crop productivity while reducing crop inputs and improving cultivation on marginal land. Ceres Inc (NASDAQ:CERE) specializes in developing seeds for producing crops for forage and biofuels. Its technology remains useful for companies that utilize plant biomass.
Growing Patent Portfolio
The company’s CEO Richard Hamilton notes that growers continue to struggle with the growing demand for feed, fiber and fuel as the global population continue to increase. The challenges according to the CEO calls for technology improvements that can guarantee better output from various forms of farming.
The patent is a great addition to Ceres Inc (NASDAQ:CERE) patent portfolio that already has 85 issued patents both in the U.S and abroad. The company also has some pending applications both in the U.S and in foreign jurisdictions that are expected to bolster its patent portfolio going forward.
